Cargando…

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment

Metabolic reprogramming and immune escape play a major role in tumorigenesis. Increasing number of studies have shown that reprogramming of glutamine metabolism is a putative determinant of the anti-tumor immune response in the tumor microenvironment (TME). Usually, the predatory uptake of glutamine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Guofeng, Zhang, Zhilei, Li, Peng, Zhang, Zhao, Zeng, Manqin, Liang, Zhijuan, Li, Dan, Wang, Liping, Chen, Yuanbin, Liang, Ye, Niu, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327201/ https://www.ncbi.nlm.nih.gov/pubmed/35897036 http://dx.doi.org/10.1186/s12964-022-00909-0

Ejemplares similares

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
por: Ma, Guofeng, et al.
Publicado: (2021)

Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2021)

Correction: Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2023)

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
por: Wang, Liping, et al.
Publicado: (2021)

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
por: Zhang, Zhao, et al.
Publicado: (2023)

Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis
por: Sun, Ningchuan, et al.
Publicado: (2019)

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
por: Wang, Liping, et al.
Publicado: (2018)

Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
por: Zhang, Zhilei, et al.
Publicado: (2023)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers
por: Zhang, Yiyin, et al.
Publicado: (2021)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis
por: Leitner, Brooks P., et al.
Publicado: (2023)

Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
por: Michalak, Krzysztof Piotr, et al.
Publicado: (2015)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Glutamine metabolism-related genes predict prognosis and reshape tumor microenvironment immune characteristics in diffuse gliomas
por: Fan, Huanhuan, et al.
Publicado: (2023)

A Five Glutamine-Associated Signature Predicts Prognosis of Prostate Cancer and Links Glutamine Metabolism with Tumor Microenvironment
por: Wang, Hai, et al.
Publicado: (2023)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells
por: Li, Xinru, et al.
Publicado: (2023)

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Hao, Yujun, et al.
Publicado: (2016)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

HepaCAM-PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation
por: He, Zhenting, et al.
Publicado: (2022)

Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
por: Foglia, Beatrice, et al.
Publicado: (2023)

Glucocorticoid deficiency causes transcriptional and post-transcriptional reprogramming of glutamine metabolism
por: Weger, Meltem, et al.
Publicado: (2018)

Glutamine/glutamate metabolism rewiring in reprogrammed human hepatocyte-like cells
por: Ballester, Maria, et al.
Publicado: (2019)

T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade
por: Lee, Kyungho, et al.
Publicado: (2023)

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review
por: Cui, Meng-Ying, et al.
Publicado: (2021)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
por: Zhu, Yifei, et al.
Publicado: (2022)

Gut Microbiota-Derived Glutamine Attenuates Liver Ischemia/Reperfusion Injury via Macrophage Metabolic Reprogramming
por: Lu, Tianfei, et al.
Publicado: (2023)

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
por: Guo, Jing, et al.
Publicado: (2021)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
por: Cox, Andrew G., et al.
Publicado: (2016)

PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
por: Li, Yaqing, et al.
Publicado: (2016)

Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis
por: Henderson, John, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rp0ff4i8b8rs46d06r1p3mrd7c